How to quote
Abad Ruiz MD, Conde Ceña C, Díaz Romero E. Problemas de salud a los 10 años del trasplante alogénico de progenitores hematopoyéticos en pacientes pediátricos. Metas Enferm jul/ago 2019; 22(6):28-32.
Mª Dolores Abad Ruiz1, Carmen Conde Ceña1, Esther Díaz Romero1
1Enfermera. Servicio de Oncología y Hematología Pediátrica. Unidad de trasplantes progenitores hematopoyéticos. Hospital Universitario Vall d’Hebron. Barcelona
Mª Dolores Abad Ruiz. Servicio de oncología y hematología pediátricas. Unidad de TPH. Hospital Universitario Vall d’ Hebron. Passeig de la Vall d’Hebr
Contact email: email@example.com
Objective: to understand the health problems presented by these patients 10 years after receiving an allogeneic stem cell transplant (allo-SCT).
Method: a descriptive cross-sectional study of those pediatric patients (from 0 to 18-year-old) who received an allo-SCT during the 2006-2007 period at the Stem Cell Transplant Unit of the Hospital Universitario Vall d’Hebron (Barcelona). Clinical data were collected through clinical records. Descriptive statistics was conducted.
Results: the sample included 28 patients with 16 years as mean age, and an age range from 11 to 26-year-old. There was an equal proportion of men and women: 50% (n= 14); 96.5% (n= 27) lived with their parents, and 92.8% (n=20) were students. The main complications were endocrinological, with 53.5% (n= 15), followed by circulatory problems with 28.5% (n= 8); 57% (n= 16) presented skin alterations, musculoskeletal alterations, and non-malignant conditions, mainly hemolytic anemia. Only 3 cases (10.7%) from the sample suffered graft versus host disease.
Conclusion: the detection of the most prevalent health conditions in allo-SCT (endocrinological, circulatory, skin, and musculoskeletal) will allow to design specific recommendations for these patients and their families, in order to minimize risks and improve their management.
allogeneic transplant; complications; pediatrics; pediatrics
Versión en Español